Bass set for first IPR trial as Shire petition proceeds

09-10-2015

Bass set for first IPR trial as Shire petition proceeds

Nejron Photo / Shutterstock.com

Hedge fund manger Kyle Bass has secured his first inter partes review (IPR) trial after the Patent Trial and Appeal Board (PTAB) instituted a challenge against a patent owned by biopharmaceutical company Shire.


Kyle Bass; PTAB; USPTO; Coalition for Affordable Drugs; Lialda; IPR; Shire; Cosmo Technologies

LSIPR